CENTOGENE

Focus: CENTOGENE is a German biotech firm specializing in genetic testing and biomarker development for rare diseases, with a global footprint including recent expansion into Abu Dhabi and Taiwan. The company operates a diagnostics-focused business model centered on undiagnosed rare disease identification.

Rare Diseases

Profile data last refreshed 8h ago · AI intelligence enriched 2w ago

Open Jobs

7+3 this month

Stable — net +3 jobs in 30d

4 added, 1 removed. Backfill posture.

Should You Work at CENTOGENE?

AI assessment

CENTOGENE is a niche rare-disease diagnostics play with strong scientific merit but opaque financial health—suitable for early-career scientists seeking rare-disease impact, risky for those prioritizing compensation transparency or job security.

Why Work Here

Focus on rare diseases with unmet diagnostic needs offers meaningful impact on patients with limited treatment options and high clinical value

Data completeness

4/9 — Basic

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Genetic Screening

Frontotemporal Dementia

N/A

Clinical Trials (1)

NCT05075187Epidemiological Study in FRONtoTemporal Dementia

N/A

Help build intelligence for CENTOGENE

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Biomarker-driven pipeline (20 active programs across rare diseases) signals sustained R&D momentum and clinical trial engagement

Geographic expansion into Asia-Pacific (Taiwan HQ) and Middle East (Abu Dhabi lab ownership) creates international career development pathways

Watch Out For

No marketed drugs in topProducts list; pipeline programs lack phase designations (all listed as N/A), suggesting pre-clinical or early-stage focus with limited near-term revenue catalysts
Only 6 active job openings and minimal public financials (revenue, cash position, R&D spend all undisclosed) raise questions about company scale, stability, and funding adequacy

Generated by Claude from CENTOGENE's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Biomarker for Glycogen Storage Diseases (BioGlycogen)

Fructose Metabolism, Inborn Errors

N/A

Clinical Trials (1)

NCT02385162Biomarker for Glycogen Storage Diseases (BioGlycogen)

N/A

Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)

Hyalinosis

N/A

Clinical Trials (1)

NCT03196115Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)

N/A

Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)

Hepato-splenomegaly

N/A

Clinical Trials (1)

NCT02298647Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)

N/A

Biomarker for Pompe Disease (BioPompe)

Cardiac Diseases

N/A

Clinical Trials (1)

NCT01457443Biomarker for Pompe Disease (BioPompe)

N/A

Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)

Lysosomal Storage Disease

N/A

Clinical Trials (1)

NCT01458613Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)

N/A

Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)

Renal Fanconi Syndrome

N/A

Clinical Trials (1)

NCT02837523Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)

N/A

Biomarker for Patients With Fabry Disease (BioFabry)

Angiokeratomas

N/A

Clinical Trials (1)

NCT02778295Biomarker for Patients With Fabry Disease (BioFabry)

N/A

Biomarker for Morquio Disease (BioMorquio)

Morquio Syndrome

N/A

Clinical Trials (1)

NCT01457456Biomarker for Morquio Disease (BioMorquio)

N/A

Induced Pluripotent Stem Cells for Niemann Pick Disease

Niemann-Pick Diseases

N/A

Clinical Trials (1)

NCT03883750Induced Pluripotent Stem Cells for Niemann Pick Disease

N/A

Biomarker for Gilbert Disease (BioGilbert)

Meulengracht Syndrome

N/A

Clinical Trials (1)

NCT02712138Biomarker for Gilbert Disease (BioGilbert)

N/A

Biomarker for Alport Syndrome (BioAlport)

Nephritis, Hereditary

N/A

Clinical Trials (1)

NCT02718027Biomarker for Alport Syndrome (BioAlport)

N/A

Biomarker for Krabbe Disease (BioKrabbe)

Krabbe Disease

N/A

Clinical Trials (1)

NCT01425489Biomarker for Krabbe Disease (BioKrabbe)

N/A

Biomarker for Hereditary AngioEdema Disease

C1 Esterase Inhibitor Deficiency

N/A

Clinical Trials (1)

NCT03029728Biomarker for Hereditary AngioEdema Disease

N/A

LIPAD - LRRK2 International Parkinson's Disease Study

Parkinson's Disease and Parkinsonism

N/A

Clinical Trials (1)

NCT04214509LIPAD - LRRK2 International Parkinson's Disease Study

N/A

Biomarker for Duchenne Muscular Dystrophy

Increased Lordosis/Scoliosis

N/A

Clinical Trials (1)

NCT02994030Biomarker for Duchenne Muscular Dystrophy

N/A

Biomarker for Metachromatic Leukodystrophy (BioMeta) Disease

Peripheral Neuropathy

N/A

Clinical Trials (1)

NCT01536327Biomarker for Metachromatic Leukodystrophy (BioMeta) Disease

N/A

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Hypomelanotic Macules

N/A

Clinical Trials (1)

NCT02654340Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

N/A

Biomarker for Niemann Pick Type C Disease (BioNPC)

Niemann-Pick Disease

N/A

Clinical Trials (1)

NCT01306604Biomarker for Niemann Pick Type C Disease (BioNPC)

N/A

Biomarker for Hypophosphatasia Disease (BioHypophos)

Defective Mineralization

N/A

Clinical Trials (1)

NCT02603042Biomarker for Hypophosphatasia Disease (BioHypophos)

N/A

Pyruvate Kinase Deficiency Epidemiological Study (PIECE)

Pyruvate Kinase Deficiency

N/A

Clinical Trials (1)

NCT03866590Pyruvate Kinase Deficiency Epidemiological Study (PIECE)

N/A

Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)

Lipoprotein Lipase Deficiency

N/A

Clinical Trials (1)

NCT03198897Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)

N/A

Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML)

Skeletal Abnormalities

N/A

Clinical Trials (1)

NCT02298673Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML)

N/A

Biomarker for Gaucher Disease: BioGaucher (BioGaucher)

Splenomegaly

N/A

Clinical Trials (1)

NCT01331642Biomarker for Gaucher Disease: BioGaucher (BioGaucher)

N/A

Peptide-based Immunization for Colon- and and Pancreas-carcinoma

Colon Neoplasm

N/A

Clinical Trials (1)

NCT03871790Peptide-based Immunization for Colon- and and Pancreas-carcinoma

N/A

Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo)

Mental Retardation

N/A

Clinical Trials (1)

NCT02298686Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo)

N/A

Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin)

Tyrosinosis

N/A

Clinical Trials (1)

NCT03284658Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin)

N/A

European Alpha-Mannosidosis Participant

Immunodeficiency

N/A

Clinical Trials (1)

NCT03651245European Alpha-Mannosidosis Participant

N/A

Biomarker for Sly Disease (MPS VII) (BioSly)

Developmental Delay

N/A

Clinical Trials (1)

NCT02298699Biomarker for Sly Disease (MPS VII) (BioSly)

N/A

Rostock International Parkinson's Disease Study (ROPAD)

Parkinson´s Disease

N/A

Clinical Trials (1)

NCT03866603Rostock International Parkinson's Disease Study (ROPAD)

N/A

Biomarker for Friedreich's Ataxia (BioFridA)

FXN Gene

N/A

Clinical Trials (1)

NCT04548921Biomarker for Friedreich's Ataxia (BioFridA)

N/A

Biomarker for Mannosidosis Disease (BioMannosidosis)

Alpha-Mannosidase B Deficiency

N/A

Clinical Trials (1)

NCT03264040Biomarker for Mannosidosis Disease (BioMannosidosis)

N/A

Biomarker for Farber Disease (BioFarber)

Farber's Lipogranulomatosis

N/A

Clinical Trials (1)

NCT02298634Biomarker for Farber Disease (BioFarber)

N/A

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)

Polyneuropathy, Amyloid

N/A

Clinical Trials (1)

NCT01705626Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)

N/A

Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease

Lysosomal Storage Diseases

N/A

Clinical Trials (1)

NCT02416661Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease

N/A

Establishment of Human Cellular Disease Models for Morquio Disease

Morquio Disease

N/A

Clinical Trials (1)

NCT03872713Establishment of Human Cellular Disease Models for Morquio Disease

N/A

COVID-19 Epidemic Response Study

Fever

N/A

Clinical Trials (1)

NCT04357496COVID-19 Epidemic Response Study

N/A

Biomarker for Wolman Disease (BioWolman)

Acid Lipase Deficiency

N/A

Clinical Trials (1)

NCT02383641Biomarker for Wolman Disease (BioWolman)

N/A

Skin biopsy

Inborn Errors of Metabolism

N/A

Clinical Trials (1)

NCT04097275Induced Pluripotent Stem Cells for the Development of Novel Drug Therapies for Inborn Errors of Metabolism (iPSC-IEM)

N/A

blood collection

Healthy Volunteers

N/A

Clinical Trials (1)

NCT06040008Investigating the Impact of Environmental Factors on the Transcriptomics Profile in Healthy Individuals

N/A

Biomarker for Cystic Fibrosis

Chronic Nasal Congestion

N/A

Clinical Trials (1)

NCT02710383Biomarker for Cystic Fibrosis

N/A

Biomarkers for Inborn Errors of Metabolism

Inborn Errors of Metabolism

N/A

Clinical Trials (1)

NCT04098198Biomarkers for Inborn Errors of Metabolism

N/A

Biomarker for Creatine Deficiency Syndromes (BioCDS)

Intellectual Disability

N/A

Clinical Trials (1)

NCT02934854Biomarker for Creatine Deficiency Syndromes (BioCDS)

N/A

Hereditary Angioedema Kininogen Assay

Hereditary Angioedema

N/A

Clinical Trials (1)

NCT04091113Hereditary Angioedema Kininogen Assay

N/A

Establishment of Human Cellular Disease Models for Wilson Disease

Wilson Disease

N/A

Clinical Trials (1)

NCT03867526Establishment of Human Cellular Disease Models for Wilson Disease

N/A

Biomarker for Hurler Disease (BioHurler)

Mucopolysaccharidosis Type I

N/A

Clinical Trials (1)

NCT02298712Biomarker for Hurler Disease (BioHurler)

N/A

Biomarkers for Hunter Syndrome

Hunter Syndrome

N/A

Clinical Trials (1)

NCT01330277Biomarkers for Hunter Syndrome

N/A

No intervention

Fabry Disease

N/A

Unraveling Genetics of HypoPhosPhatasia (HPP Genetics)

Hypophosphatasia

N/A

The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement

Fabry Disease

N/A

Clinical Trials (1)

NCT01268241The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease

N/A